Donor leukocyte infusions in acute lymphocytic leukemia

Bone Marrow Transplantation

Volumn 26, Issue 5, 2000, Pages 511-516

  Collins, R H ^a,b   Goldstein, S ^c   Giralt, S ^d   Levine, J ^e   Porter, D ^f   Drobyski, W ^g   Barrett, J ^h   Johnson, M ^b   Kirk, A ^b   Horowitz, M ^g,i   Parker, P ^j  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

ⁱ International Bone Marrow Transplant Registry   (United States)

^j CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

more..

Author keywords

Acute lymphocytic leukemia; Adoptive immunotherapy; Donor leukocyte infusions

Indexed keywords

ALPHA INTERFERON; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IFOSFAMIDE; INTERLEUKIN 2; MELPHALAN; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADOPTIVE IMMUNOTHERAPY; ADULT; ARTICLE; ASPIRATION PNEUMONIA; BONE MARROW TRANSPLANTATION; BRAIN INFARCTION; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE TRANSFUSION; MALE; MULTICENTER STUDY; ORGAN DONOR; PRIORITY JOURNAL; RESPIRATORY FAILURE; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033832579     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702555     Document Type: Article

References (37)

1. Treatment of murine leukemia with X-rays and homologous bone marrow
2. Principles of graft-versus-leukemia reactivity
3. Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation
4. How does bone-marrow transplantation cure leukaemia?
5. Graft-versus-leukemia reactions after bone marrow transplantation
6. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
7. Donor leukocyte infusions for chronic myeloid leukemia after allogeneic bone marrow transplantation
8. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose
9. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia
10. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse
11. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia
12. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation
13. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
14. The first clinical use of donor leukocyte infusions for the treatment of leukemia relapsing after allogeneic bone marrow transplantation
15. Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation
16. Transient complete remission of acute lymphoblastic leukemia in relapse after allogeneic bone marrow transplantation induced by donor leukocyte transfusions
17. Grade IV graft-versus-host disease and a 1-year remission following donor leukocyte transfusion for treatment of relapsed acute lymphoblastic leukemia (letter)
18. Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients
19. Haematological remission induced by donor leukocyte infusion in a case of Philadelphia positive acute lymphoblastic leukaemia relapsing after allogeneic bone marrow transplantation
20. Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion
21. Relapse of a Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: Sustained molecular remission after early and dose-escalating infusion of donor leukocytes
22. Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantation
23. Infusion of donor-derived peripheral blood leukocytes after transplantation of cord blood progenitor cells can increase the graft-versus-leukaemia effect
24. Use of donor lymphocytes in extra-medullary relapse of childhood acute lymphoblastic leukaemia following bone marrow transplantation
25. Extramedullary relapse after favorable molecular response to donor leukocyte infusions for recurring acute leukemia
26. Donor leukocyte infusion as salvage therapy in an adult with relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation
27. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
28. Chronic graft-vs.-host syndrome in man. A long-term clinicopathological study of 20 Seattle patients
29. Non-parametric estimation from incomplete observations
30. A note on confidence intervals and bands for the survival curve based on transformations
31. Adoptive immunotherapy in chimeras for the treatment of leukemia
32. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
33. Expression of costimulatory molecules in human leukemias
34. Expression and function of adhesion receptors on normal B cells and B cell non-Hodgkin's lymphomas
35. Natural history of HLA expression during tumor development
36. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen
37. Adoptive immunotherapy with antigen-specific T cells